Back to Rathbones Group PLC Rathbones Group PLC

ADAPYADAPY
29 quarters

Position history for Rathbones Group PLCRathbones Group PLC's holdings in ADAPTIMMUNE THERAPEUTICS PLC Spon ADS Each Rep 6 Ord Shs

Rathbones Group PLC previously held 0 shares of ADAPY (ADAPTIMMUNE THERAPEUTICS PLC Spon ADS Each Rep 6 Ord Shs), worth $0 as of 2026-Q1.

Final Value

$0

Final Shares

0

Total Value Change

-$1.2M

Total Shares Change

-285,722

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Exited
0
-100.0%
$00.0%$0.02
0
2025-Q4
Increased
865,636
+100.0%
$22,5060.0%$0.03
21
2025-Q3
Unchanged
432,818
0.0%
$56,2660.0%$0.14
0
2025-Q2
Unchanged
432,818
0.0%
$103,7460.0%$0.25
0
2025-Q1
Unchanged
432,818
0.0%
$85,2650.0%$0.21
0
2024-Q4
Unchanged
432,818
0.0%
$233,1590.0%$0.55
0
2024-Q3
Unchanged
432,818
0.0%
$411,3500.0%$0.98
0
2024-Q2
Unchanged
432,818
0.0%
$421,9540.0%$0.98
0
2024-Q1
Unchanged
432,818
0.0%
$683,8520.0%$1.58
0
2023-Q4
Unchanged
432,818
0.0%
$343,2240.0%$0.79
0
2023-Q3
Unchanged
432,818
0.0%
$337,5980.0%$0.78
0
2023-Q2
Unchanged
432,818
0.0%
$400,3560.0%$0.94
0
2023-Q1
Unchanged
432,818
0.0%
$471,7710.0%$1.06
0
2022-Q4
Unchanged
432,818
0.0%
$631,9140.0%$1.46
0
2022-Q3
Unchanged
432,818
0.0%
$465,0000.0%$1.06
0
2022-Q2
Unchanged
432,818
0.0%
$736,0000.0%$1.71
0
2022-Q1
Unchanged
432,818
0.0%
$892,0000.0%$2.06
0
2021-Q4
Decreased
432,818
-0.0%
$1.6M0.0%$3.87
0
2021-Q3
Unchanged
432,921
0.0%
$2.2M0.0%$5.20
0
2021-Q2
Unchanged
432,921
0.0%
$1.8M0.0%$4.39
0
2021-Q1
Unchanged
432,921
0.0%
$2.3M0.0%$5.05
0
2020-Q4
Unchanged
432,921
0.0%
$2.3M0.0%$5.41
0
2020-Q3
Decreased
432,921
-2.3%
$3.5M0.1%$7.66
0
2020-Q2
Increased
442,921
+11.1%
$4.4M0.1%$9.29
30
2020-Q1
Decreased
398,853
-43.2%
$1.1M0.0%$2.75
0
2019-Q4
Unchanged
702,575
0.0%
$843,0000.0%$1.16
0
2019-Q3
Decreased
702,575
-0.3%
$1.1M0.0%$1.47
0
2019-Q2
Increased
704,472
+146.6%
$2.8M0.1%$4.02
42
2019-Q1
New
285,722
-
$1.2M0.0%$4.30
35

Other major holders of ADAPY: RA CAPITAL MANAGEMENT, L.P., Avoro Capital Advisors LLC, Capital World Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used